OxyBand Technologies
OxyBand Technologies is a privately-held medical device company that develops and sells the FDA 510(k) cleared OxyBand Wound Dressing, which continuously delivers pure medical-grade oxygen to damaged tissue for up to 5 days. It serves hospitals, burn centers, wound care clinics, and military medical providers in the United States.
- Company typePrivate
- Founded2003
- HeadquartersMinneapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What OxyBand Technologies does
OxyBand Technologies, Inc. is a privately-held medical device company that has developed and commercialized the OxyBand Wound Dressing, an FDA 510(k) cleared (K043063) multi-layer wound care product that continuously delivers medical-grade oxygen (99%) directly to damaged tissue for up to 5 days without an attached tank or generator. Its underlying technology is a patented directionally permeable gas-emitting reservoir that stores and releases pure oxygen through a multi-layer dressing, claimed to be the only oxygen-delivering wound dressing with this continuous 5-day delivery claim. The company was founded in 2003 by scientists and engineers focused on therapeutic gas applications, holds 68 patent matters (12 granted, 5 allowed), and has completed three clinical trials — two civilian randomized controlled trials and one DOD-funded military trial conducted by the U.S. Army Institute of Surgical Research — demonstrating 25-30% faster healing, reduced pain, and zero infections versus standard of care.
The firm operates primarily in the United States and Puerto Rico with a small staff (11-50 employees), selling a single commercial product available in two sizes (4.5" x 5.5" and 7" x 9"). Its go-to-market combines direct sales with distribution through McKesson and Lighthouse for the Blind Industries (which also manufactures the product under SKILCRAFT via AbilityOne federal channels), backed by 3M's manufacturing engineering support. Marketing relies on clinical evidence dissemination through peer-reviewed publications (Journal of Burn Care & Research, Vascular Disease Management) and presentations at conferences such as APWCA, the American Burn Association, the Society for Advanced Wound Care, and the Military Health Services Research Symposium. CEO Amie E. Franklin leads the company, with key clinical advocacy from Dr. Jeffrey Niezgoda.
Revenue mechanics consist of one-time unit purchases of the wound dressing through direct and distributor channels at non-publicly-listed prices. The company's explicit pipeline positions the wound dressing as the first of a longer line of therapeutic gas medical devices for adjacent applications including eye diseases, orthopedics, regenerative medicine, antimicrobial healing, and cosmetic procedures — potentially using nitric oxide alongside oxygen — though only the wound dressing is currently commercialized.
OxyBand Technologies firmographics
Firmographics- Name
- OxyBand Technologies
- Legal name
- OxyBand Technologies, Inc.
- Website
- https://oxyband.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- OxyBand Technologies is a privately-held medical device company that develops and sells the FDA 510(k) cleared OxyBand Wound Dressing, which continuously delivers pure medical-grade oxygen to damaged tissue for up to 5 days. It serves hospitals, burn centers, wound care clinics, and military medical providers in the United States.
- Ownership category
- akta.pro rank
OxyBand Technologies industry classification
Industry- Product category
- Advanced Wound Care Medical Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film) (HLAHALAA)
- akta.pro secondary industry
- Wound Healing & Dermatologic Regeneration (HLAMANAG)
Keywords
Where OxyBand Technologies is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
OxyBand Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- OxyBand Wound Dressing Sales: One-time purchase of FDA-cleared wound care medical devices sold through direct sales and distribution partners including McKesson and Lighthouse for the Blind. Products are manufactured in the USA with manufacturing partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard OxyBand Wound Dressing products |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
OxyBand Technologies product offering
Product offeringCore offering
OxyBand Technologies develops and sells the FDA 510(k) cleared OxyBand Wound Dressing™, a multi-layer wound dressing that uses a patented directionally permeable gas-emitting reservoir to continuously deliver pure medical-grade oxygen (99%) directly to the wound site for up to 5 days without an attached tank or generator. The product is offered in two standard sizes (4.5" x 5.5" and 7" x 9") and is manufactured through partners (Lighthouse for the Blind Industries and 3M) and distributed through direct sales, McKesson, and the SKILCRAFT/AbilityOne federal channel.
Product overview
OxyBand Technologies offers a single unified product — the OxyBand Wound Dressing™ — an FDA 510(k) cleared medical device that represents the company's premiere therapeutic oxygen wound care product. The dressing is a multi-layer transdermal oxygen therapy system that comes pre-filled with high levels of oxygen between the layers and delivers continuous oxygen directly to wounds for up to 5 days. The company describes this as "the beginning of a long line of therapeutic gas medical device products for Wound Care to Eye Care," with a pipeline of healing technologies under development focusing on therapeutic gases such as oxygen and nitric oxide for applications including traumatic wounds, diabetic ulcers, eye diseases, orthopedics, regenerative medicine, antimicrobial healing, and cosmetic procedures. Currently, only the OxyBand Wound Dressing is commercially available, with future products planned.
Differentiator
Problem solved
Functional benefit
Brands
- OxyBand Wound Dressing™: FDA 510(k) cleared wound dressing that delivers pure oxygen to wounds for up to 5 days, proven in clinical trials to accelerate healing, reduce pain, and prevent infection
Products and services
- OxyBand Wound Dressing™ FDA 510(k) cleared (K043063) multi-layer wound dressing that delivers continuous pure medical-grade oxygen (99%) directly to the wound site for up to 5 days using a patented directionally permeable gas-emitting reservoir. Indicated for traumatic, acute, burn, donor site, pressure ulcer, diabetic foot ulcer, and chronic skin ulcer wounds in clinical, military, and home-care settings; clinically demonstrated to accelerate healing by 25-30%, reduce pain, and prevent infection.
Quantifiable outcome
- Accelerated wound healing by 25-30% compared to standard of care and placebo dressings in clinical trials
- +3 more outcomes
Companies that use OxyBand Technologies
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
OxyBand Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
OxyBand Technologies partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered major and core.
- U.S. Army Institute of Surgical Research (USAISR)majorUSAISR conducted an independent, prospective, randomized, controlled clinical trial evaluating OxyBand Wound Dressing efficacy on donor site wounds. Study funded by DOD. Results presented at American Burn Association Meeting April 2013. USAISR is a Center of Excellence for Battlefield Health, Trauma and Burn Research.
- Lighthouse for the Blind Industries (LHB)coreLighthouse for the Blind manufactures, assembles, warehouses, and distributes OxyBand wound dressings. LHB is an FDA registered facility with ISO 9001 registration, ISO 13485 compliance, and 21 CFR 820 CGMP compliance. Products are manufactured in a level 8 (100,000) environmentally controlled cleanroom. LHB has specialized expertise in oxygenation, packaging, and shipping of products using gases.
- 3M Companymajor3M worked closely with OxyBand on complex materials, engineering, and manufacturing processes for OxyBand wound dressings. 3M utilized its vast resources and experience to improve the manufacturing process and create a highly safe and efficient manufacturing process. 3M is ranked #21 on Fortune's worldwide most admired companies list and #1 in the medical equipment industry.
- McKessoncoreMcKesson distributes OxyBand Wound Dressing as one of the major medical supply distributors in the United States.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
OxyBand Technologies competitors and assessment
Company assessmentBroad incumbents
- ConvaTec: ConvaTec's AQUACEL hydrofiber and DuoDERM hydrocolloid dressings are widely used advanced wound care products in hospitals and chronic wound clinics, competing head-to-head with OxyBand for the same prescriber base.
- Smith & Nephew: Global advanced wound care leader with PICO single-use NPWT, ALLEVYN foam dressings, and a broad wound management portfolio sold into hospitals and home health. Competes with OxyBand across advanced wound dressings and adjunctive oxygen/NPWT modalities.
- Coloplast: Coloplast's Biatain and Comfeel advanced wound dressings target the same chronic wound (diabetic foot ulcer, pressure ulcer) prescriber base as OxyBand, particularly in home care and wound clinic channels.
- 3M Health Care (KCI): 3M owns the V.A.C. NPWT franchise via KCI and is also OxyBand's named manufacturing process partner. Competes directly in advanced wound care and brings scale, salesforce, and global reimbursement infrastructure OxyBand lacks.
- Mölnlycke Health Care: Mölnlycke's Mepilex, Mepitel, and Avance NPWT systems are standard-of-care advanced wound dressings globally. Comparable as a direct competitor in foam/silicone advanced wound dressings where OxyBand seeks to differentiate on oxygen delivery.
Others
- Cardinal Health: Cardinal Health is one of the largest US medical product distributors alongside McKesson; comparable as a distribution/partner channel that controls hospital and wound clinic access for wound care products including OxyBand's category.
Emerging players
- MiMedx: MiMedx markets dehydrated amniotic membrane allografts (e.g., EpiFix) for chronic wound healing, with clinical evidence specifically for diabetic foot ulcers and venous leg ulcers — the same use cases OxyBand targets with its oxygen delivery dressing.
- Organogenesis: Organogenesis sells Apligraf and other skin substitute and advanced wound care products into chronic wound clinics. Comparable as an emerging specialist competing for the same diabetic foot ulcer and venous leg ulcer prescribing physicians.
Direct peers
- Integra LifeSciences: Integra offers regenerative wound matrices (Integra Dermal Regeneration Template) and the Medihoney and wound dressing portfolio. Comparable as a specialist in advanced and regenerative wound care where OxyBand also competes in chronic and complex wounds.
- AOTI Inc. AOTI makes the Topical Wound Oxygen (TWO) therapy system, which similarly delivers oxygen directly to chronic wounds but via a reusable chamber/device rather than a self-contained dressing. It is the closest mechanistic peer to OxyBand in the localized oxygen-for-wound-healing category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
OxyBand Technologies social profiles
Digital presenceOxyBand Technologies compliance and trust
Trust signalCompliance3 records
OxyBand Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
OxyBand Technologies leadership team
Management profileNumber of profiles
Profiles1 record
OxyBand Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OxyBand Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OxyBand Technologies
What does OxyBand Technologies do?
OxyBand Technologies develops and sells the FDA 510(k) cleared OxyBand Wound Dressing™, a multi-layer wound dressing that uses a patented directionally permeable gas-emitting reservoir to continuously deliver pure medical-grade oxygen (99%) directly to the wound site for up to 5 days without an attached tank or generator. The product is offered in two standard sizes (4.5" x 5.5" and 7" x 9") and is manufactured through partners (Lighthouse for the Blind Industries and 3M) and distributed through direct sales, McKesson, and the SKILCRAFT/AbilityOne federal channel.
Is OxyBand Technologies a public or private company?
OxyBand Technologies is a private company. It is classified as unknown and is currently operating.
When was OxyBand Technologies founded?
OxyBand Technologies was founded in 2003. It employs 11 to 50 people.
Where is OxyBand Technologies based?
OxyBand Technologies is headquartered in Minneapolis, United States, in the North America region.
How does OxyBand Technologies make money?
One revenue line is on record: oxyBand Wound Dressing Sales.
Who are OxyBand Technologies's main competitors?
Broad incumbents on record are ConvaTec, Smith & Nephew, Coloplast, 3M Health Care (KCI) and Mölnlycke Health Care. Cardinal Health is listed as an others. Emerging players are MiMedx and Organogenesis. Direct peers are Integra LifeSciences and AOTI Inc..
Does OxyBand Technologies have an API?
No public API is recorded for OxyBand Technologies.
What industry is OxyBand Technologies in?
OxyBand Technologies's product category is Advanced Wound Care Medical Devices. Its primary akta.pro industry code is HLAHALAA, Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film), with a secondary code of HLAMANAG, Wound Healing & Dermatologic Regeneration. Its NAICS code is 3391 and its SIC code is 3841.